메뉴 건너뛰기




Volumn 25, Issue 3, 1988, Pages 911-914

The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water‐soluble formazan

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84986452945     PISSN: 0022152X     EISSN: 19435193     Source Type: Journal    
DOI: 10.1002/jhet.5570250340     Document Type: Article
Times cited : (120)

References (18)
  • 14
    • 84986435509 scopus 로고    scopus 로고
    • in “2nd Edition of Textbook of Aids: Etiology, Diagnosis, Treatment and Prevention”, in press.
    • Boyd, M.R.1
  • 16
    • 84986433930 scopus 로고
    • 748
    • (1926) Beilstein , vol.14 , pp. 814-817
  • 17
  • 18
    • 84986498337 scopus 로고    scopus 로고
    • The unprecedented scale of the in vitro program conceived of and directed by M. B. led R. S. to focus on tetrazolium assay technology and to define the need for a water‐soluble formazan. A general design stragety was developed by K. P. The initial small sample of formazan 2 was selected from the NCI repository by K. P. The authors thank M. G. for this sample. The first small‐scale synthesis of 1 from 2 was achieved by authors D. B. and E. H. whose work was funded by NCI contract NO1‐CM‐27571. The authors thank Dr. Roger Haugwitz, Project Officer of that contract for his cooperation in this project. The large‐scale synthesis was achieved by authors J. L. P., P. A. R., W. A. B. and M. N. S. whose work was funded by NCI contract NO1‐CM‐67926. The authors thank Dr. Karl Flora, the Project Officer for that contract, for his cooperation. The biological evaluation of XTT was performed by D. S., M. A. and A. M. whose work was supported by NCI contract NO1‐CO‐23910.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.